Merck & Co.
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
US
IE
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Merck & Co. (MRK) Business News
Track Merck & Co. in real time with a live news feed covering Merck & Co. stock news, official press releases, company announcements, and an archive of historical Merck & Co. news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30
April Dogs Of The Dow: One To Buy
Barclays names top 4 defensive stocks to weather global uncertainty
Infinimmune, Merck enter into antibody discovery pact
Infinimmune Enters Collaboration with Merck to Discover Novel Human Antibody Therapeutics
Financial Planning Hawaii Inc. Makes New $679,000 Investment in Merck & Co., Inc. $MRK
Boston Common Asset Management LLC Grows Stock Holdings in Merck & Co., Inc. $MRK
April Dogs Of The Dow: One To Buy
Barclays names top 4 defensive stocks to weather global uncertainty
Infinimmune, Merck enter into antibody discovery pact
Financial Planning Hawaii Inc. Makes New $679,000 Investment in Merck & Co., Inc. $MRK
Boston Common Asset Management LLC Grows Stock Holdings in Merck & Co., Inc. $MRK
Merck's drug reduced bad cholesterol by 64.6% in late-stage trial
How Merck's New Cholesterol Buster Will 'Move The Needle' 'By Removing The Needle'
Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
Cypress Wealth Services LLC Purchases 9,854 Shares of Merck & Co., Inc. $MRK
Chesley Taft & Associates LLC Has $6.37 Million Holdings in Merck & Co., Inc. $MRK
Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30
7:00 AM | Wednesday | Apr 1, 2026
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30.
Read full article
Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30
Business WireRAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30.
Read full article
April Dogs Of The Dow: One To Buy
Seeking AlphaVerizon (VZ) is the only Dow stock in April 2026 meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by robust free cash flow. Analyst forecasts suggest the top ten Dow dividend stocks could deliver average net gains of 45.76% by April 2027, albeit with above-market volatility. Dividend dogcatcher strategy prioritizes stocks where dividends from $1K invested surpass share price; currently, only VZ qualifies, but more may reach this on market pullbacks.
Read full article
Barclays names top 4 defensive stocks to weather global uncertainty
InvezzAs Dow Jones slides into the “correction territory” and the benchmark S&P 500 index logs its fifth consecutive week of losses, investors are increasingly desperate for a port in the storm. According to Barclays' senior analyst Andrew Ferremi, the market has shifted into a new, volatile era where geopolitical tensions, oil price spikes, and AI-driven disruption are “no longer episodic shocks but persistent features of the investment landscape.
Read full article
Infinimmune, Merck enter into antibody discovery pact
ReutersBiotech firm Infinimmune said on Tuesday it has entered into a deal with Merck , that could be worth up to about $838 million in milestone payments, to discover and develop multiple antibodies for various undisclosed disease targets.
Read full article
Infinimmune Enters Collaboration with Merck to Discover Novel Human Antibody Therapeutics
Business WireALAMEDA, Calif.--(BUSINESS WIRE)-- #AI--Infinimmune Enters Collaboration with Merck to Discover Novel Human Antibody Therapeutics.
Read full article
Financial Planning Hawaii Inc. Makes New $679,000 Investment in Merck & Co., Inc. $MRK
Defense WorldFinancial Planning Hawaii Inc. bought a new stake in shares of Merck and Co., Inc. (NYSE: MRK) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,446 shares of the company's stock, valued at approximately $679,000.
Several other large
Boston Common Asset Management LLC Grows Stock Holdings in Merck & Co., Inc. $MRK
Defense WorldBoston Common Asset Management LLC lifted its holdings in Merck and Co., Inc. (NYSE: MRK) by 3.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 255,480 shares of the company's stock after acquiring an additional 7,762 shares during the quarter.
Merck
April Dogs Of The Dow: One To Buy
Seeking AlphaVerizon (VZ) is the only Dow stock in April 2026 meeting the ideal of annual dividends from $1K invested exceeding its share price, supported by robust free cash flow. Analyst forecasts suggest the top ten Dow dividend stocks could deliver average net gains of 45.76% by April 2027, albeit with above-market volatility. Dividend dogcatcher strategy prioritizes stocks where dividends from $1K invested surpass share price; currently, only VZ qualifies, but more may reach this on market pullbacks.
Read full article
Barclays names top 4 defensive stocks to weather global uncertainty
InvezzAs Dow Jones slides into the “correction territory” and the benchmark S&P 500 index logs its fifth consecutive week of losses, investors are increasingly desperate for a port in the storm. According to Barclays' senior analyst Andrew Ferremi, the market has shifted into a new, volatile era where geopolitical tensions, oil price spikes, and AI-driven disruption are “no longer episodic shocks but persistent features of the investment landscape.
Read full article
Infinimmune, Merck enter into antibody discovery pact
ReutersBiotech firm Infinimmune said on Tuesday it has entered into a deal with Merck , that could be worth up to about $838 million in milestone payments, to discover and develop multiple antibodies for various undisclosed disease targets.
Read full article
Financial Planning Hawaii Inc. Makes New $679,000 Investment in Merck & Co., Inc. $MRK
Defense WorldFinancial Planning Hawaii Inc. bought a new stake in shares of Merck and Co., Inc. (NYSE: MRK) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,446 shares of the company's stock, valued at approximately $679,000.
Several other large
Boston Common Asset Management LLC Grows Stock Holdings in Merck & Co., Inc. $MRK
Defense WorldBoston Common Asset Management LLC lifted its holdings in Merck and Co., Inc. (NYSE: MRK) by 3.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 255,480 shares of the company's stock after acquiring an additional 7,762 shares during the quarter.
Merck
Merck's drug reduced bad cholesterol by 64.6% in late-stage trial
ReutersMerck's oral drug reduced bad cholesterol by 64.6% in a late-stage trial, it said on Monday, as the company looks for its next blockbuster candidate.
Read full article
How Merck's New Cholesterol Buster Will 'Move The Needle' 'By Removing The Needle'
Investors Business DailyMerck's experimental cholesterol buster easily outperformed a triplet of medications, the Dow Jones component said Monday.
Read full article
Merck's Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
Business WireRAHWAY, N.J.--(BUSINESS WIRE)--Enlicitide, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions Compared to Oral Non-Statin Therapies.
Read full article
Cypress Wealth Services LLC Purchases 9,854 Shares of Merck & Co., Inc. $MRK
Defense WorldCypress Wealth Services LLC increased its position in shares of Merck and Co., Inc. (NYSE: MRK) by 256.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,689 shares of the company's stock after buying an additional 9,854 shares during the period.
Cypress
Chesley Taft & Associates LLC Has $6.37 Million Holdings in Merck & Co., Inc. $MRK
Defense WorldChesley Taft and Associates LLC lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 9.4% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 60,485 shares of the company's stock after acquiring an additional 5,213 shares
Read full article